Clinical Physiology of Circulation

ISSN 1814-6910 (Print)
ISSN 2410-9134 (Online)

 

Chief Editor

Leo A. Bockeria, MD, PhD, DSc, Professor, Academician of Russian Academy of Sciences, President of Bakoulev National Medical Research Center for Cardiovascular Surgery


Issue's catalogue ➤ КФК. 2018; 15 (2): 65-144 ➤ Диагностика и коррекция нарушений гемостаза в кардиохирургии

Diagnostics and correction of hemostasis disorders in cardiac surgery

Authors: N.N. Samsonova

Company:
Bakoulev National Medical Research Center for Cardiovascular Surgery, Ministry of Health of the Russian Federation, Rublevskoe shosse, 135, Moscow, 121552, Russian Federation

E-mail: Сведения доступны для зарегистрированных пользователей.

DOI: https://doi.org/10.24022/1814- 6910-2018-15-2-69-74

UDC: 616.15-07-08-089

Link: Clinical Physiology of Blood Circulaiton. 2018; 15 (2): 69-74

Quote as: Samsonova N.N. Diagnostics and correction of hemostasis disorders in cardiac surgery. Klinicheskaya Fiziologiya Krovoobrashcheniya (Clinical Physiology of Circulation, Russian journal). 2018; 15 (2): 69–74 (in Russ.). DOI: 10.24022/1814-6910-2018-15-2-69-74

Keywords:  cardiovascular surgery bleeding recombinant coagulation factors laboratory diagnostics

Received / Accepted:  19.01.2018/02.02.2018

Full text:  

Abstract

Cardiac surgery with cardiopulmonary bypass often involves both bleeding and thrombosis, these being the possible caus- es of different complications in postoperative period. Apart surgical causes bleeding can also occur when cellular and plasma hemostasis components are damaged. Early diagnosis of imbalance in hemostasis system is very important for corrections of complications in operative and postoperative periods. High-tech blood analyzers of the latest generation are used in the clinical laboratory diagnostics division of Bakoulev NMRCCS. Center specialists assessed safety and effec- tiveness of recombinant coagulation factors of various age group patients, including infants in the first year of life. They also carried out studies on diagnostics and correction of heparin-induced thrombocytopenia and disseminated intravas- cular coagulation syndrome. The experience and diagnostic algorithms developed in cooperation with clinicians in the Bakoulev NMRCCS can be recommended for surgical facilities.

References

  1. Willems A., Savan V., Faraoni D., De Ville A., Rozen L., Demulder A., Van der Linden P. Heparin reversal after cardiopulmonary bypass: are point-of-care coagulation tests interchangeable? J. Cardiothorac. Vasc. Anesth. 2016; 5: 1184–9. DOI: 10.1053/j.jvca. 2016.03.004

  2. Shen S., Zhang J., Wang W., Zheng J., Xie Y. Impact of intra-operative cell salvage on blood coagulation in high-bleeding-risk patients undergoing cardiac surgery with cardiopulmonary bypass: a prospective randomized and controlled trial. J. Transl. Med. 2016; 14 (1): 228. DOI: 10.1186/s12967-016-0986-6

  3. Van Poucke S., Stevens K., Wetzels R., Kicken C., Verhezen P., Theunissen M. et al. Early platelet recovery following cardiac surgery with cardiopulmonary bypass. Platelets. 2016; 27 (8): 751–7.

  4. Meesters M.I., Veerhoek D., de Lange F., de Vries J.W., de Jong J.R., Romijn J.W. et al. Effect of high or low protamine dosing on postoperative bleeding following heparin anticoagulation in cardiac surgery. A randomised clinical trial. Thromb. Haemost. 2016; 116 (2): 251–61. DOI: 10.1160/TH16-02-0117

  5. Самсонова Н.Н., Климович Л.Г., Рогальская Е.А. Патогенез послеоперационных коагулопатий. Клиническая физиология кровообращения. 2014; 4: 17–24. [Samsonova N.N., Klimovich L.G., Rogal'skaya E.A. Pathogenesis of postoperative coagulopathy. Klinicheskaya Fiziologiya Krovoobrashcheniya (Clinical Physiology of Circulation, Russian journal). 2014; 4: 17–24 (in Russ.).]

  6. Шаталов К.В., Самсонова Н.Н., Свирин П.В., Арнаутова И.В., Тимченко Л.И., Климович Л.Г., Козар Е.Ф. Хирургическая коррекция врожденных пороков сердца у детей с гемофилией А. Сердечнососудистые заболевания. Бюллетень НЦССХ им. А.Н. Бакулева РАМН. 2009; 9 (6): 14. [Shatalov K.V., Samsonova N.N., Svirin P.V., Arnautova I.V., Timchenko L.I., Klimovich L.G., Kozar E.F. Surgical correction of congenital heart diseases in children with hemophilia A. Serdechno-Sosudistye Zabolevaniya. Byulleten' NTSSK imeni A.N. Bakuleva RAMN (Bulletin of Bakoulev Center for Cardiovascular Diseases, Russian journal). 2009; 9 (6): 14 (in Russ.).]

  7. Рагимов А.А., Еременко А.А., Никифоров Ю.В. Трансфузиология в реаниматологии. М.: МИА; 2005. [Ragimov A.A., Eremenko A.A., Nikiforov Yu.V. Transfusiology in intensive care. Moscow: MIA; 2005 (in Russ.).]

  8. Millas B.L., Jobes D.R., Gorma R.C. Management of bleeding and coagulopathy after heart surgery. Semin. Thorac. Cardiovasc. Surg. 2000; 12 (4): 326–36.

  9. Nakayama Y., Nakajima Y., Tanaka K.A., Sessler D.I., Maeda S., Iida J. et al. Thromboelastometry-guided intraoperative haemostatic management reduces bleeding and red cell transfusion after paediatric cardiac surgery. Br. J. Anaesth. 2014; 113 (5): 847–54. DOI: 10.1093/bja/aeu194

  10. Самсонова Н.Н., Климович Л.Г., Диасамидзе К.Э., Купряшов А.А. Использование рекомбинантного активированного фактора VII в кардиохирургии. Тромбоз, гемостаз и реология. 2011; 4: 41–7. [Samsonova N.N., Klimovich L.G., Diasamidze K.E., Kupryashov A.A. Use of recombinant activated factor VII in cardiac surgery. Tromboz, Gemostaz i Reologia (Thrombosis, Hemostasis and Rheology, Russian journal). 2011; 4: 41–7 (in Russ.).]

  11. Самсонова Н.Н., Рыбка М.М., Лобачева Г.В., Климович Л.Г., Козар Е.Ф., Щеголькова Т.С., Рогальская Е.А. Исследование эффективности и безопасности применения препарата коагил-VII – эптаког альфа (активированный) при повышенной кровоточивости у больных, оперированных в условиях искусственного кровообращения. Тромбоз, гемостаз и реология. 2012; 3: 52–6. [Samsonova N.N., Rybka M.M., Lobacheva G.V., Klimovich L.G., Kozar E.F., Shegolkova T.S., Rogalskaya E.A. The study of efficiency and safety of COAGIL-VII – eptacog alfa (activated) in cases of increased haemorrhage in patients undergoing cardio-pulmonary bypass. Tromboz, Gemostaz i Reologia (Thrombosis, Hemostasis and Rheology, Russian journal). 2012; 3: 52–6 (in Russ.).]

  12. Котова А.Н., Самсонова Н.Н., Туманян М.Р., Климович Л.Г. Особенности гемостаза и реологии крови у детей с «цианотическими» врожденными пороками сердца первого месяца и первого года жизни. В кн.: Материалы 25 симпозиума по реологии. Осташков; 2010: 149–51. [Kotova A.N., Samsonova N.N., Tumanyan M.R., Klimovich L.G. Features of hemostasis and rheology of blood in children with “cyanotic” congenital heart defects of the first month and the first year of life. In: Materials of the 25th symposium on rheology. Ostashcov; 2010: 149–51 (in Russ.).]

  13. Faraoni D., Willems A., Romlin B.S., Belisle S., Van der Linden P. Development of a specific algorithm to guide haemostatic therapy in children undergoing cardiac surgery: a single-centre retrospective study. Br. J. Anaesth. 2015; 114 (1): 91–102. DOI: 10.1093/bja/ aeu339

  14. Niebler R.A., Woods K., Markows K.J., Chanayen N.S., Hoffman G., Mitchell M.E. et al. A pilot study of antitrombin replacement prior to cardiopulmonary bypass in neonates. Artif. Organs. 2016; 40 (1): 80–5. DOI: 10.1111Jaoz. 126 42

  15. Самсонова Н.Н., Рыбка М.М., Климович Л.Г., Рогальская Е.А., Хинчагов Д.Я., Татарян Ф.Э. и др. Применение концентрата протромбинового комплекса у детей раннего возраста, оперированных на сердце в условиях искусственного кровообращения. Тромбоз, гемостаз и реология. 2015; 1 (61): 22–7. [Samsonova N.N., Rybka M.M., Klimovich L.G., Rogalskaya E.A., Khinchagov D.Ya., Tataryan F.E. et al. Use of prothrombin complex concentrate in early infants undergoing cardiac surgery with cardiopulmonary bypass. Tromboz, Gemostaz i Reologia (Thrombosis, Hemostasis and Rheology, Russian journal). 2015; 1 (61): 22–7 (in Russ.).]

  16. Stevens L.M., Noiseux N., Prieto I., Hardy J.F. Major transfusions remain frequent despite the generalized use of tranexamic acid: an audit of 3322 patients undergoing cardiac surgery. Transfusion. 2016; 56 (7): 1857–65. DOI: 10.1111/trf.13615

  17. Koster A., Faraoni D., Levy J.H. Antifibrinolytic therapy for cardiac surgery: an update anesthesiology. 2015; 123 (1): 214–21.

  18. Самсонова Н.Н., Климович Л.Г., Андреев Н.В., Козар Е.Ф., Серегин К.О. Исследование эффективности и безопасности транексамовой кислоты при операциях на сердце в условиях искусственного кровообращения. Грудная и сердечно-сосудистая хирургия. 2009; 6: 63–70. [Samsonova N.N., Klimovich L.G., Andreev N.V., Kozar E.F., Seregin K.O. Investigation of the efficacy and safety of tranexamic acid in cardiac surgery in condition of artificial circulation. Grudnaya i Serdechno-Sosudistaya Khirur-giya (Russian Journal of Thoracic and Cardiovascular Surgery). 2009; 6: 63–70 (in Russ.).]

  19. Рыбка М.М., Рогальская Е.А., Мещанов Б.В., Самсонова Н.Н., Климович Л.Г., Хинчагов Д.Я. и др. Периоперационная динамика активности антитромбина у пациентов с ишемической болезнью сердца в сочетании с патологией митрального клапана. Клиническая физиология кровообращения. 2017; 14 (2): 91–5. [Rybka М.М., Rogal'skaya E.A., Meshchanov B.V., Samsonova N.N., Klimovich L.G., Khinchagov D.Ya. et al. Perioperative antithrombin activity in patients with coronary heart disease combined with pathology of the mitral valve. Klinicheskaya Fiziologiya Krovoobrashcheniya (Clinical Physiology of Circulation, Russian journal). 2017; 14 (2): 91–5 (in Russ.).]

  20. Legnani C., Cini M., Pili C., Boggian O., Frascaro M., Palareti G. Evaluation of a new automated panel of assays for the detection of anti-PF4/heparin antibodies in patients suspected of having heparin-induced thrombocytopenia. Thromb. Haemost. 2010; 104 (2): 402–9.

  21. Самсонова Н.Н., Климович Л.Г., Рогальская Е.А., Ярустовский М.Б., Козар Е.Ф., Кротенко Н.П., Горбенко И.Ю. Критерии оценки синдрома ДВС у пациентов с заболеваниями сердца и сосудов. Тромбоз, гемостаз и реология. 2014; 4 (60): 50–4. [Samsonova N.N., Klimovich L.G., Rogalskaya E.A., Yarustovskiy M.B., Kozar E.F., Krotenko N.P., Gorbenko I.Yu. Estimation criteria of DIC-syndrome in patients with cardiovascular disease. Tromboz, Gemostaz i Reologia (Thrombosis, Hemostasis and Rheology, Russian journal). 2014; 4 (60): 50–4 (in Russ.).]

  22. Рогальская Е.А. Диагностическое и прогностическое значение современных биохимических маркеров септических осложнений у больных после операций на сердце и сосудах: Дис. ... канд. мед. наук. М.; 2017. [Rogalskaya E.A. Diagnostic and prognostic value of modern biochemical markers of sepsis in patients after cardiovascular surgery: Cand. Med. Sc. Diss. Moscow; 2017 (in Russ.).]

About Authors

Samsonova Nataliya Nikolaevna, Dr. Med. Sc., Professor, Head of Clinical Laboratory Diagnostic Division; orcid.org/0000-0001-5711-6897

 If you found mistakes, select text and press Alt+A